Yamaguchi Y - Search Results

1

The clinical efficacy of intratumoral OK-432 administration in advanced cancer patients.

Toge T, Kuninobu H, Yamaguchi Y, Baba N, Kegoya Y, Hattori T. Toge T, et al. Among authors: yamaguchi y. Jpn J Surg. 1988 Nov;18(6):668-74. doi: 10.1007/BF02471528. Jpn J Surg. 1988. PMID: 3266768

2

[Clinical efficacy of LAK cell adoptive immunotherapy in advanced cancer patients].

Toge T, Takayama T, Kegoya Y, Kuninobu H, Yamaguchi Y, Hattori T. Toge T, et al. Among authors: yamaguchi y. Nihon Geka Gakkai Zasshi. 1989 Sep;90(9):1455-8. Nihon Geka Gakkai Zasshi. 1989. PMID: 2586438 Japanese.

3

Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.

Yamaguchi Y, Satoh Y, Miyahara E, Noma K, Funakoshi M, Takashima I, Sawamura A, Toge T. Yamaguchi Y, et al. Anticancer Res. 1995 Sep-Oct;15(5B):2201-6. Anticancer Res. 1995. PMID: 8572625

4

Effects of the oral or intratumoral administration of OK432 on the immuno-reactivities of regional lymph nodes in gastric cancer patients.

Yanagawa E, Toge T, Yamaguchi Y, Kuninobu H, Kuroi K, Kegoya Y, Baba N, Takayama T, Sato Y. Yanagawa E, et al. Among authors: yamaguchi y. Jpn J Surg. 1991 May;21(3):297-303. doi: 10.1007/BF02470950. Jpn J Surg. 1991. PMID: 1857033

5

The analysis of lymphocyte surface receptors recognized by wheat germ agglutinin for negative regulation of immune responses in cancer patients.

Yamaguchi Y, Toge T, Baba N, Kuninobu H, Kegoya Y, Takayama T, Hattori T. Yamaguchi Y, et al. Jpn J Surg. 1990 Jan;20(1):51-5. doi: 10.1007/BF02470713. Jpn J Surg. 1990. PMID: 2106047

6

Lymphocyte subpopulations in peripheral blood and the spleen from gastric cancer patients.

Kuroi K, Sato Y, Takayama T, Baba N, Yamaguchi Y, Toge T. Kuroi K, et al. Among authors: yamaguchi y. Hiroshima J Med Sci. 1990 Jun;39(2):23-7. Hiroshima J Med Sci. 1990. PMID: 2228724

7

Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.

Yamaguchi Y, Ohshita A, Kawabuchi Y, Hihara J, Miyahara E, Noma K, Toge T. Yamaguchi Y, et al. Int J Oncol. 2004 Apr;24(4):959-66. Int J Oncol. 2004. PMID: 15010836

8

Blocking of lymphocyte surface binding sites for the soluble suppressor factor by protein-bound polysaccharide, PSK.

Toge T, Yamaguchi Y, Kegoya Y, Baba N, Yanagawa E, Hattori T. Toge T, et al. Among authors: yamaguchi y. Int J Immunopharmacol. 1989;11(1):9-12. doi: 10.1016/0192-0561(89)90093-3. Int J Immunopharmacol. 1989. PMID: 2651333

9

[Surgical stress and immunosuppression in cancer patients].

Toge T, Kegoya Y, Yamaguchi Y, Baba N, Kuninobu H, Takayama T, Yanagawa E, Hattori T. Toge T, et al. Among authors: yamaguchi y. Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-1):1115-21. Gan To Kagaku Ryoho. 1989. PMID: 2730016 Japanese.

10

Role of the spleen in immunosuppression of gastric cancer: predominance of suppressor precursor and suppressor inducer T cells in the recirculating spleen cells.

Toge T, Kuroi K, Kuninobu H, Yamaguchi Y, Kegoya Y, Baba N, Hattori T. Toge T, et al. Among authors: yamaguchi y. Clin Exp Immunol. 1988 Dec;74(3):409-12. Clin Exp Immunol. 1988. PMID: 2976622 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,236 results

Search Page

Filters